Vimpat®

Active substance

Lacosamide

Holder

Clinigen group

Status

Closed

Indication

Partial-onset or generalized tonic clonic seizures in patients ≥ 16 years of age coming from the SP0994 clinical trial

Public documents

Approbation

Information for the patient

Informed consent

Last update

15/05/2019

Last updated on 13/02/2024